Lobby organisation
Servier
Company · Health & pharma · HQ: France · Transparency Register entry
As of 7 November 2026, Servier appears in 8 declared MEP meetings (8 different MEPs), most often with European People's Party.
In their own words
“Founded to serve health, Servier is a global pharmaceutical group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs.”
Read the rest of the statementShow less of the statement
“As a world leader in cardiology, Servier’s ambition is to become a renowned, focused and innovative player in oncology by targeting hard-to-treat cancers. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine. Headquartered in France, Servier relies on a strong geographical footprint in over 130 countries with 20 000 employees and achieved a revenue of €6.9 billion in 2025.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 8 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (3 in 2023). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 8 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 22 Jan 2026 | Adam Jarubas | Cardiovascular health |
| 19 Nov 2024 | Eero Heinäluoma | Current Affairs |
| 10 Oct 2024 | András Tivadar Kulja | European Healthcare |
| 23 Jul 2024 | Ruggero Razza | Incontro conoscitivo e scambio di vedute sul mandato del Parlamento europeo |
| 27 Oct 2023 | Laura Ballarín Cereza | Pharmaceutical Package (Regulation) |
| 30 Aug 2023 | Tomislav Sokol | NCDs report |
| 28 Feb 2023 | Nicolás González Casares | Medicines |
| 5 Dec 2019 | Sergey Lagodinsky | Intellectual Property Rights |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.